BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18416659)

  • 21. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
    Pepe S; Korbonits M; Iacovazzo D
    J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Craniopharyngioma in Pediatrics and Adults.
    Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
    Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic testing in the management of pituitary disease.
    Coopmans EC; Korbonits M
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?
    Chiloiro S; De Marinis L
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1744-1759. PubMed ID: 34425741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.
    Oikonomou E; Barreto DC; Soares B; De Marco L; Buchfelder M; Adams EF
    J Neurooncol; 2005 Jul; 73(3):205-9. PubMed ID: 15980970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary tumors in children and adolescents.
    Lafferty AR; Chrousos GP
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4317-23. PubMed ID: 10599681
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of pediatric sellar tumors.
    Jane JA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():720-6. PubMed ID: 18317443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the treatment of pituitary adenomas: familial and genetic considerations.
    Daly AF; Beckers A
    Acta Clin Belg; 2008; 63(6):418-24. PubMed ID: 19170361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis.
    Boikos SA; Stratakis CA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R80-7. PubMed ID: 17613552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenomas in childhood.
    Singh SK; Aggarwal R
    Indian J Pediatr; 2005 Jul; 72(7):583-91. PubMed ID: 16077242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective multicentric study of pituitary incidentalomas.
    Day PF; Guitelman M; Artese R; Fiszledjer L; Chervin A; Vitale NM; Stalldecker G; De Miguel V; Cornaló D; Alfieri A; Susana M; Gil M
    Pituitary; 2004; 7(3):145-148. PubMed ID: 16328565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
    Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and Management of Pituitary Adenomas: A Review.
    Tritos NA; Miller KK
    JAMA; 2023 Apr; 329(16):1386-1398. PubMed ID: 37097352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary adenomas: an overview.
    Lake MG; Krook LS; Cruz SV
    Am Fam Physician; 2013 Sep; 88(5):319-27. PubMed ID: 24010395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic aspects of familial isolated pituitary adenomas.
    Vasilev V; Daly A; Naves L; Zacharieva S; Beckers A
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):37-41. PubMed ID: 22584704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Alterations in Sporadic Pituitary Tumors.
    Bi WL; Larsen AG; Dunn IF
    Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.